Physician profile
Laura E Oki
NPI 1699131441
$389.74
in general payments reported to CMS, 2019-2025
10 companies · $321 in 2025
The $321 reported for 2025 was more than what 90% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.39 · 2023: $16.47 · 2024: $33.86 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $186.66 | 2025 | |
| Galderma Laboratories, L.P. | $45.85 | 2023-2025 | Dysport |
| Gilead Sciences, INC. | $29.80 | 2025 | |
| Astellas Pharma US INC | $27.99 | 2025 | Veozah |
| Merck Sharp & Dohme LLC | $19.25 | 2024 | Gardasil, Gardasil 9 |
| Evofem Biosciences, INC. | $18.39 | 2022 | |
| Esperion Therapeutics, INC. | $18.16 | 2025 | Nexletol |
| Revance Therapeutics, INC. | $15.17 | 2025 | Daxxify |
| Bayer Healthcare Pharmaceuticals INC. | $14.61 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.86 | 2025 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Oki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.